Brimonidine Tartrate; Carbachol Patent Expiration
Brimonidine Tartrate; Carbachol was first introduced by Visus Therapeutics Inc
Brimonidine Tartrate; Carbachol Patents
Given below is the list of patents protecting Brimonidine Tartrate; Carbachol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Yuvezzi | US12268662 | Formulations Comprising Carbachol And Brimonidine To Enhance Anti- Presbyopia Effects | Nov 10, 2042 | Visus |
| Yuvezzi | US8455494 | Preparations And Methods For Ameliorating Or Reducing Presbyopia | May 24, 2030 | Visus |
Brimonidine Tartrate; Carbachol's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List